article · International Journal of Infectious Diseases
Under programmatic conditions, the BPaL-L regimen achieved the highest treatment success while maintaining manageable safety profiles. These findings provide valuable evidence to guide patient management and support implementation of novel MDR/RR-TB regimens in high-burden settings.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ijid.2026.108473
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
